FDA Inspection 1030016 — Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company
The FDA completed an inspection of Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company on Sep 11, 2017 in Manati, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 11, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Manati, PR (United States)